Picture of Polypid logo

PYPD Polypid Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Annual cashflow statement for Polypid, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:20-F20-F20-F20-F20-F
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-36.9-42.6-39.6-23.9-29
Depreciation
Non-Cash Items15.94.754.64.923.52
Other Non-Cash Items
Changes in Working Capital-1.694.35-1.08-0.111.92
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-21.6-32.4-34.3-17.2-22
Capital Expenditures-0.781-2.65-1.77-0.196-0.076
Purchase of Fixed Assets
Other Investing Cash Flow Items-4039.618.34-0.254
Change in Net Investments
Other Investing Cash Flow
Cash from Investing Activities-40.836.916.63.8-0.33
Financing Cash Flow Items-0.125-0.125
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities62.81.0316.49.9832.4
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.415.55-1.31-3.4610.1